Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2012
May 2012, Vol 3, No 3
May 2012, Vol 3, No 3
Votrient Receives New Indication for Advanced Soft-Tissue Sarcoma
FDA Approvals, News & Updates
May 2012, Vol 3, No 3
The US Food and Drug Administration (FDA) approved the oral agent pazopanib (Votrient; GlaxoSmith-Kline) for the treatment of patients with advanced soft-tissue sarcoma who have previously received chemotherapy.
Read Article
Payer Trends in Oncology: Challenges and Solutions
By
Caroline Helwick
May 2012, Vol 3, No 3
Houston, TX—The need to optimize the treatment of patients with cancer while using healthcare resources wisely—in other words, providing “value-based cancer care”—is not a topic of debate, but how to achieve this pressing goal is far from clear. In a panel discussion during the Association for Value-Based Cancer Care’s Second Annual Conference, strategists from the payer side of the issue discussed the current trends and the challenges they are facing.
Read Article
Ready or Not, Value-Based Purchasing Is Coming Near You
By
Neil Canavan
ACCC Annual Meeting
May 2012, Vol 3, No 3
Baltimore, MD—It has been said that a journey of a thousand miles begins with a single step. It is with this sensibility that Donald P. Howard of the Centers for Medicare & Medicaid Services (CMS) began his presentation at the 2012 Association of Community Cancer Centers (ACCC) meeting, detailing the current state of the hospital value-based purchasing (VBP) program.
Read Article
Optimal Care for Patients with Cancer: Who Decides?
By
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
Hollywood, FL—Cancer care today is influenced by an ever-broadening array of players, and what was once an intimate relationship between patient and physician now involves multiple decision makers. At the 2012 National Comprehensive Cancer Network (NCCN) meeting, a panel of various stakeholder groups addressed the questions of what and who defines “optimal care” for today’s patient.
Read Article
AVBCC Second Stakeholder Integration Conference
May 2012, Vol 3, No 3
Houston, TX—On March 29-31, 2012, approximately 200 oncologists, payers, employers, managed care executives, pharmacy benefit managers, and other stakeholders convened for the Second Annual Stakeholder Integration Conference of the Association for Value-Based Cancer Care (AVBCC). The mission of the conference was to align the various perspectives around the central needs of defining value in cancer care and developing strategies for enhancing patient outcomes.
Read Article
Evolving Practice Standards for Cancer Programs from the Commission on Cancer
By
M. Asa Carter, CTR
Cancer Care
,
Personalized Medicine
May 2012, Vol 3, No 3
What is the most important challenge faced by a person who is diagnosed with cancer today? Opinions will differ, but most patients want to be assured that they will work with a group of multispecialty physicians who will provide recommendations for care that provide the best possible outcomes, that all options for effective treatment will be available to them, that care will be provided in a safe and comfortable hospital or other facility, and that the healthcare staff will care about their problems and concerns with managing treatment, professional issues, and family issues.
Read Article
Can Whole-Genome Sequencing Predict Future Cancer?
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—For the individual at average risk for disease, whole-genome sequencing (WGS)—mapping the sequence of one’s full set of genetic material—is not a crystal ball to reliably predict future health, according to a study presented at the 2012 American Association for Cancer Research meeting.
Read Article
Metformin Protects Against Several Cancers
By
Richard Hyer
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—Metformin cannot seem to stay out of the news. This antidiabetes drug that is derived from the French lilac is now also thought to possibly protect against liver cancer, lower the risk for oral cancer, improve prognosis of pancreatic cancer in diabetic patients, and increase response to melanoma tumors with BRAF mutations when used in combination with a common cancer drug, according to several studies presented at the 2012 American Association for Cancer Research meeting.
Read Article
Advances in Personalized Medicine: Focus on Prostate and Brain Cancers
By
Richard Hyer
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—Targeting prostate cancer with extreme accuracy, using tissue oxygen content to predict its recurrence, and using breast cancer drugs on brain tumors were a few highlights of a news conference on advances in personalized medicine at the 2012 American Association for Cancer Research meeting.
Read Article
Coping with Cancer Drug Shortages: Practical Tips
By
Neil Canavan
ACCC Annual Meeting
May 2012, Vol 3, No 3
Baltimore, MD—According to Ernest Anderson, Jr, MS, RPh, System Vice President of Pharmacy, Steward Health Care System, Boston, MA, “If you’re not familiar with the drug shortage issue, you must be living under a rock.”
Read Article
Page 3 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma